Respironics, Inc. 11-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 11-K
| |
|
|
| (Mark One) |
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
|
|
For the fiscal year ended December 31, 2006 |
|
|
|
|
|
OR |
|
|
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
|
|
For the transition period from to |
Commission file number: 000-16723
A. Full title of the plan and the address of the plan, if different from that of the issuer
named below:
Respironics, Inc.
Retirement Savings Plan
B. Name of issuer of the securities held pursuant to the plan and the address of its
principal executive office:
Respironics, Inc.
1010 Murry Ridge Lane
Murrysville, PA 15668-8525
Respironics, Inc. Retirement Savings Plan
Audited Financial Statements and Supplemental Schedule
As of December 31, 2006 and 2005, and
for the Years Ended December 31, 2006 and 2005
Contents
| |
|
|
|
|
|
|
|
3-4 |
|
Audited Financial Statements |
|
|
|
|
|
|
|
5 |
|
|
|
|
6 |
|
|
|
|
7-9 |
|
|
|
|
|
|
Schedule H, Line 4i — Schedule of Assets (Held at End of Year) |
|
|
10 |
|
| EX-1 |
| EX-2 |
2
Report of Independent Registered Public Accounting Firm
The Plan Administrator
Respironics, Inc. Retirement Savings Plan
Murrysville, Pennsylvania
We have audited the accompanying statements of net assets available for benefits of the
Respironics, Inc. Retirement Savings Plan (Plan) as of December 31, 2006 and the related statements
of changes in net assets available for benefits for the year then ended. These financial statements
are the responsibility of the Plan’s management. Our responsibility is to express an opinion on
these financial statements based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. Our
audit included consideration of internal control over financial reporting as a basis for designing
audit procedures that are appropriate in the circumstances, but not for the purpose of expressing
an opinion on the effectiveness of the Plan’s internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements. An audit also
includes assessing the accounting principles used and significant estimates made by management, and
evaluating the overall financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the net assets available for benefits of the Plan as of December 31, 2006, and the
changes in net assets available for benefits for the year then ended, in conformity with accounting
principles generally accepted in the United States of America.
Our audit was performed for the purpose of forming an opinion on the financial statements taken as
a whole. The accompanying supplemental schedule of assets (held at end of year) as of December 31,
2006, is presented for purposes of additional analysis and is not a required part of the basic
financial statements but is supplementary information required by the Department of Labor’s Rules
and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of
1974. This supplemental schedule is the responsibility of the Plan’s management. The supplemental
schedule has been subjected to the auditing procedures applied in the audit of the financial
statements and, in our opinion, is fairly stated in all material respects in relation to the
financial statements taken as a whole.
/s/ Schneider Downs & Company, Inc.
Pittsburgh, Pennsylvania
June 20, 2007
3
Report of Independent Registered Public Accounting Firm
The Plan Administrator
Respironics, Inc. Retirement Savings Plan
Murrysville, Pennsylvania
We have audited the accompanying statements of net assets available for benefits of the
Respironics, Inc. Retirement Savings Plan as of December 31, 2005 and the related statements of
changes in net assets available for benefits for the year then ended. These financial statements
are the responsibility of the Plan’s management. Our responsibility is to express an opinion on
these financial statements based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. We
were not engaged to perform an audit of the Plan’s internal control over financial reporting. Our
audit included consideration of internal control over financial reporting as a basis for designing
audit procedures that are appropriate in the circumstances, but not for the purpose of expressing
an opinion on the effectiveness of the Plan’s internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall
financial statement presentation. We believe that our audit provides a reasonable basis for our
opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the net assets available for benefits of the Plan at December 31, 2005, and the changes
in its net assets available for benefits for the year then ended, in conformity with U.S. generally
accepted accounting principles.
Our audit was performed for the purpose of forming an opinion on the financial statements taken as
a whole.
/s/ Ernst & Young LLP
Pittsburgh, Pennsylvania
May 10, 2006
4
Respironics, Inc. Retirement Savings Plan
Statements of Net Assets Available for Benefits
| |
|
|
|
|
|
|
|
|
| |
|
December 31 |
|
|
December 31 |
|
| |
|
2006 |
|
|
2005 |
|
Assets |
|
|
|
|
|
|
|
|
Investments, at fair value |
|
$ |
111,963,062 |
|
|
$ |
91,003,633 |
|
Receivables: |
|
|
|
|
|
|
|
|
Participants’ contributions |
|
|
321,367 |
|
|
|
454,795 |
|
Employer’s contributions |
|
|
213,458 |
|
|
|
289,125 |
|
|
|
|
|
|
|
|
|
|
|
534,825 |
|
|
|
743,920 |
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Due to broker for securities purchased |
|
|
(3,739 |
) |
|
|
(3,737 |
) |
|
|
|
|
|
|
|
Net assets available for benefits |
|
$ |
112,494,148 |
|
|
$ |
91,743,816 |
|
|
|
|
|
|
|
|
See accompanying notes.
5
Respironics, Inc. Retirement Savings Plan
Statements of Changes in Net Assets Available for Benefits
| |
|
|
|
|
|
|
|
|
| |
|
Year Ended |
|
|
Year Ended |
|
| |
|
December 31 |
|
|
December 31 |
|
| |
|
2006 |
|
|
2005 |
|
Net assets available for benefits at beginning of period |
|
$ |
91,743,816 |
|
|
$ |
70,213,570 |
|
Contributions: |
|
|
|
|
|
|
|
|
Participants’ |
|
|
10,166,719 |
|
|
|
8,891,362 |
|
Rollovers |
|
|
925,918 |
|
|
|
1,060,481 |
|
Employer’s |
|
|
4,167,630 |
|
|
|
3,510,854 |
|
Transfers from acquired plan |
|
|
— |
|
|
|
634,344 |
|
Investment income |
|
|
152,552 |
|
|
|
101,367 |
|
Net realized and unrealized appreciation in fair value of investments |
|
|
10,212,889 |
|
|
|
10,575,861 |
|
Participant withdrawals |
|
|
(4,875,376 |
) |
|
|
(3,244,023 |
) |
|
|
|
|
|
|
|
Net increase |
|
|
20,750,332 |
|
|
|
21,530,246 |
|
|
|
|
|
|
|
|
Net assets available for benefits at end of period |
|
$ |
112,494,148 |
|
|
$ |
91,743,816 |
|
|
|
|
|
|
|
|
See accompanying notes.
6
Notes to Financial Statements
December 31, 2006
1. Significant Accounting Policies
Basis of Accounting
The accounting records of the Respironics, Inc. Retirement Savings Plan (the Plan) are maintained
on the accrual basis.
Valuation of Investments
The fair value of the Plan’s investments in registered investment companies and common collective
funds are based on quoted market prices, which represent the net asset values of shares held by the
Plan on the last business day of the period. Shares of Respironics, Inc. common stock are valued at
the last trade price on the last business day of the period. Participant loans are valued at their
outstanding unpaid principal balance, which approximates fair value.
Use of Estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting
principles requires management to make estimates that affect the amounts reported in the financial
statements and accompanying notes. Actual results could differ from those estimates.
Recent Accounting Pronouncements
As of December 31, 2006 the Plan adopted the Financial Accounting Standards Board (FASB) Staff
Position FSP AAG INV-1 and Statement of Position No. 94-4-1, “Reporting of Fully Benefit-Responsive
Investment Contracts Held by Certain Investment Companies Subject to the AICPA Investment Company
Guide and Defined-Contribution Health and Welfare and Pension Plans” (the FSP). The FSP requires
the Statement of Net Assets Available for Benefits to present the fair value of the Plan’s
investments as well as the adjustment from fair value to contract value for the fully
benefit-responsive investment contracts. Implementation of this FSP will have no impact on Net
Assets of the Plan and will only affect the presentation of the investments within the Plan’s
Statement of Net Assets Available for Benefits and the presentation of net realized and unrealized
appreciation in fair value of investments within the Plan’s Statements of Changes in Net Assets
Available for Benefits. The implementation of the FSP did not have a material impact on the Plan’s
financial statements.
In September 2006, the FASB issued Statement No. 157, “Fair Value Measurement” (FAS 157), which
establishes a framework for measuring fair value under generally accepted accounting principles and
expands disclosure about fair value measurements. FAS 157 is effective for financial statements
issued with fiscal years beginning after November 15, 2007. The Plan’s management does not believe
that the adoption of FAS 157 will have a material impact on the Plan’s financial statements.
In February 2007, the FASB issued Statement No. 159, “The Fair Value Option for Financial Assets
and Financial Liabilities” (FAS 159). The fair value option established by FAS 159 permits
entities to choose to measure eligible items at fair value at specified election dates. Unrealized
gains and losses on items for which the fair value option has been elected are reported in earnings
at each subsequent reporting date. FAS 159 is effective as of the beginning of an entity’s first
fiscal year that begins after November 15, 2007. The Plan’s management does not believe that the
adoption of FAS 159 will have a material impact on the Plan’s financial statements.
2. Plan Description
The Plan is a defined contribution plan qualifying under Section 401(a) of the Internal Revenue
Code. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974
(ERISA). The following description of the Plan provides only general information. Participants
should refer to the Plan Document and the Summary Plan Description for a more complete description
of the Plan’s provisions.
7
Contributions
Employees of Respironics, Inc. and participating subsidiaries (the Company), upon date of hire, are
eligible to participate in, and contribute to the Plan. An employee electing to participate in the
Plan (a participant) may contribute from 1% to 75% of their compensation through payroll
deductions, subject to certain limitations. The plan sponsor matches 100% of participant
contributions up to a maximum of 3% of the participant’s compensation, as defined by the Plan. The
participant and Company matching contributions are funded in cash on a biweekly basis among the
available investment options based upon the election of each participant.
Discretionary contributions may be authorized by the Board of Directors of the Company. No
discretionary contributions were made during the years ended December 31, 2006 or December 31,
2005.
Investments
Participants may elect to invest their salary deferral contributions in any one of the available
investment options or may split their contributions among these options. Individual accounts are
established for each plan participant and are credited for participant and Company contributions
and an allocation of earnings based on the participant’s account balance.
Termination and Vesting
Participants become immediately vested in their contributions, Company matching, and any Company
discretionary contributions plus accrual of earnings thereon. Upon termination of service,
participants receive their entire contributions and the Company’s matching and any discretionary
contributions through a lump-sum payment at termination or at a future date of their choosing
(except for amounts under $1,000 that are paid at termination).
Participants may elect to withdraw all or a portion of their account without terminating employment
with the Company upon reaching age 59-1/2, or under special hardship provisions.
Although the Company expects to continue the Plan indefinitely, it maintains the right to
discontinue contributions and terminate the Plan, subject to the provisions of ERISA. In the event
of a termination of the Plan, each participant’s account balance would be distributed.
Loans
The Plan Administrator may authorize a loan to a participant for an amount up to 50% of the
participant’s vested account balance. The minimum amount that may be borrowed is $1,000, and the
maximum amount varies with the participant’s vested account balance, but cannot exceed $50,000. The
Plan Administrator will determine a reasonable rate of interest for each loan upon consideration of
the rate of interest then prevailing in the local community for similar loans, currently prime plus
1%. Loans are generally required to be repaid in five years in equal installments; however, the
term of the loan may be extended if the intended use of the funds is to acquire a residence. A
participant may have no more than three loans outstanding under the Plan at any one time.
3. Plan Investments
The following presents investments that represent 5% or more of the fair value of the Plan’s net
assets:
| |
|
|
|
|
|
|
|
|
| |
|
December 31 |
|
| |
|
2006 |
|
|
2005 |
|
American Century Small Company Fund* |
|
$ |
5,264,825 |
* |
|
$ |
5,041,155 |
|
Fidelity Contrafund |
|
|
29,867,947 |
|
|
|
26,191,574 |
|
Fidelity Diversified International Fund |
|
|
16,273,375 |
|
|
|
11,195,841 |
|
Fidelity Freedom 2020 Fund |
|
|
13,075,695 |
|
|
|
11,021,532 |
|
Fidelity Managed Income Portfolio |
|
|
8,685,207 |
|
|
|
7,719,677 |
|
Fidelity Mid-Cap Stock Fund |
|
|
8,249,268 |
|
|
|
5,684,415 |
|
PIMCO Total Return Fund |
|
|
5,633,035 |
|
|
|
4,467,847 |
* |
Respironics, Inc. common stock |
|
|
9,040,597 |
|
|
|
9,817,693 |
|
* Investment balance represents less than 5% of the Plan’s net assets and is shown for
comparative purposes only.
8
All investments are participant directed.
The Plan’s investments (including gains and losses on investments bought and sold, as well as held
during the period) appreciated (depreciated) in value as follows:
| |
|
|
|
|
|
|
|
|
| |
|
Year Ended |
|
|
Year Ended |
|
| |
|
December 31 |
|
|
December 31 |
|
| |
|
2006 |
|
|
2005 |
|
Registered investment companies |
|
$ |
9,815,876 |
|
|
$ |
7,488,409 |
|
Common stock |
|
|
148,523 |
|
|
|
2,818,621 |
|
Common collective funds |
|
|
248,490 |
|
|
|
268,831 |
|
|
|
|
|
|
|
|
|
|
$ |
10,212,889 |
|
|
$ |
10,575,861 |
|
|
|
|
|
|
|
|
4. Income Tax Status
The Plan has received a determination letter from the Internal Revenue Service dated November 28,
2005, stating that the Plan is qualified under Section 401(a) of the Internal Revenue Code (the
Code) and, therefore, the related trust is exempt from taxation. Once qualified, the Plan is
required to operate in conformity with the Code to maintain its qualification. The Plan
Administrator believes the Plan is being operated in compliance with the applicable requirements of
the Code and therefore, believes that the Plan is qualified and the related trust is tax exempt.
5. Transactions With Parties in Interest
The Plan’s trustee and record keeper is Fidelity Investments (Fidelity). Certain plan investments
represent shares of mutual funds managed by Fidelity, therefore these transactions qualify as
party-in-interest. Fees paid by the Plan to Fidelity for tax preparation and recordkeeping
services totaled $29,188 and $23,307 for the year ended December 31, 2006 and December 31, 2005,
respectively.
All administrative expenses of the Plan are paid by Plan participants, except for tax preparation
and audit fees which are paid by the Company.
6. Risks and Uncertainties
The Plan invests in various investment securities. Investment securities are exposed to various
risks such as interest rate, market, and credit risks. Due to the level of risk associated with
certain investment securities, it is at least reasonably possible that changes in the values of
investment securities will occur in the near term and that such changes could materially affect
participants’ account balances and the amounts reported in the statements of net assets available
for benefits.
7. Acquisitions
On April 1, 2005, the Company acquired 100% of the outstanding common stock of Mini-Mitter, Inc.
(Mini-Mitter). Mini-Mitter develops and sells sleep and physiological monitoring products to
commercial sleep laboratories and other medical, pharmaceutical and health research institutions
involved in clinical trials.
Mini-Mitter employees became eligible to participate in the Plan on July 15, 2005. Additionally, on
July 1, 2005, the Company’s Board of Directors approved the termination of the Mini Mitter Co Inc.,
401K Profit Sharing Plan and Trust (the Mini-Mitter Plan). In conjunction with these events, on
July 15, 2005, all Mini-Mitter Plan assets ($634,344) were transferred into the Respironics, Inc.
Retirement Savings Plan.
9
EIN 25-1304989 Plan #: 001
Schedule H, Line 4i — Schedule of Assets
(Held at End of Year)
December 31, 2006
| |
|
|
|
|
|
|
| Issuer |
|
Description of Investments |
|
Market Value |
|
|
|
|
|
|
|
Fidelity*
|
|
Fidelity Contrafund
|
|
$ |
29,867,947 |
|
Fidelity*
|
|
Fidelity Diversified International Fund
|
|
|
16,273,375 |
|
Fidelity*
|
|
Fidelity Mid-Cap Stock Fund
|
|
|
8,249,268 |
|
Fidelity*
|
|
Fidelity Freedom Income Fund
|
|
|
162,348 |
|
Fidelity*
|
|
Fidelity Managed Income Portfolio
|
|
|
8,685,207 |
|
Fidelity*
|
|
Fidelity Freedom 2005 Fund
|
|
|
65,392 |
|
Fidelity*
|
|
Fidelity Freedom 2010 Fund
|
|
|
2,546,655 |
|
Fidelity*
|
|
Fidelity Freedom 2015 Fund
|
|
|
516,265 |
|
Fidelity*
|
|
Fidelity Freedom 2020 Fund
|
|
|
13,075,695 |
|
Fidelity*
|
|
Fidelity Freedom 2025 Fund
|
|
|
1,664,338 |
|
Fidelity*
|
|
Fidelity Freedom 2030 Fund
|
|
|
2,369,871 |
|
Fidelity*
|
|
Fidelity Freedom 2035 Fund
|
|
|
767,051 |
|
Fidelity*
|
|
Fidelity Freedom 2040 Fund
|
|
|
984,071 |
|
American Beacon
|
|
American Beacon Large Cap Value Fund
|
|
|
1,313,219 |
|
American Century
|
|
American Century Small Company Fund
|
|
|
5,264,825 |
|
Pacific Investment Management Company (PIMCO)
|
|
PIMCO Total Return Fund
|
|
|
5,633,035 |
|
Spartan
|
|
Spartan US Equity Index Fund
|
|
|
2,903,323 |
|
Respironics, Inc.*
|
|
Respironics, Inc. common stock
|
|
|
9,040,597 |
|
Participant loans*
|
|
(interest rates: 5.00% — 10.50%)
|
|
|
2,194,486 |
|
|
|
Interest-bearing cash
|
|
|
386,094 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
111,963,062 |
|
|
|
|
|
|
|
|
* Indicates a party in interest.
10
REQUIRED INFORMATION
The financial statements and related report, prepared in accordance with the financial reporting
requirements of ERISA, listed below are furnished for the Respironics, Inc. Retirement Savings Plan
(the Plan). The pages referred to are the numbered pages in the Plan’s audited financial statements
for the years ended December 31, 2006 and 2005.
| |
|
|
|
|
| |
|
Pages |
|
Reports of Independent Registered Public Accounting Firms |
|
|
3-4 |
|
Audited Financial Statements and Supplemental Schedule |
|
|
5-9 |
|
11
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons
who administer the employee benefit plan) have duly caused this annual report to be signed on
behalf of the Plan by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
RESPIRONICS, INC.
RETIREMENT SAVINGS PLAN
|
|
| |
By /s/ William R. Wilson
|
|
| |
William R. Wilson |
|
| |
Plan Administrator |
|
| |
Dated: June 20, 2007
12
Respironics, Inc.
Retirement Savings Plan
Annual Report on Form 11-K
For the Years Ended December 31, 2006 and 2005
EXHIBIT INDEX
| |
|
|
| Exhibit No. |
|
Description of Exhibits |
1
|
|
Consent of Independent Registered Public Accounting Firm, Schneider Downs & Company Inc, filed herewith. |
2
|
|
Consent of Independent Registered Public Accounting Firm, Ernst & Young LLP, filed herewith. |
13